The effect of the topical application of different pentoxifylline concentrations on the patch test results of nickel-sensitive patients.
Saricaoğlu
Hayriye
H
Başkan
Emel Bülbül
EB
Tunali
Sükran
S
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D017449:Dermatitis, Allergic Contact / Q000188:drug therapy* / Q000209:etiology*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005782:Gels; D006801:Humans; D008297:Male; D008875:Middle Aged; D009532:Nickel / Q000009:adverse effects*; D010328:Patch Tests; D010431:Pentoxifylline / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D003879:Dermatologic Agents; D005782:Gels; D014409:Tumor Necrosis Factor-alpha; D009532:Nickel; D010431:Pentoxifylline